Healthcare IT market to be worth $229B by 2020

The global healthcare IT market is estimated to reach $228.79 billion by 2020, growing at a annual rate of 13.4 percent, according to a report by Research and Markets.

The healthcare IT market is driven by increasing healthcare expenditures, increasing use of data-driven technologies, introduction of various healthcare reforms and changing regulations and growing pressure on healthcare organizations to curb healthcare costs. The growing need of healthcare insurance providers to efficiently manage an in-depth record of claims and reimbursements is also expected to contribute to the growth.

Yet many regions are slow to adopt the newest programs of healthcare information due to the high costs incurred for implementation, maintenance, and upgrading services; dearth of in-house IT skilled resources; and inadequate IT infrastructure. Rising incidences of data breaches, high costs incurred on training staff, technical difficulties in integrating healthcare IT solutions, and interoperability issues are other key reasons there is a slowing down the adoption of healthcare IT solutions, especially in emerging markets.

The global health IT market is divided into healthcare provider solutions, healthcare payer solutions, and HCIT outsourcing services. The healthcare provider solutions segment is further segmented into clinical solutions and non-clinical solutions. The HCIT outsourcing services segment is further categorized into provider HCIT outsourcing services, payer HCIT outsourcing services, operational HCIT outsourcing services, and IT infrastructure management services.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.